Lixte Biotechnology Holdings Inc. (LIXT)
NASDAQ · Healthcare
Lixte Biotechnology Holdings Inc. Operating Income 2010–2015
Lixte Biotechnology Holdings Inc. annual/quarterly operating income history and growth rate from 2010 to 2013. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Lixte Biotechnology Holdings Inc. operating income for the quarter ending September 30, 2013 was -313052, a 62.65% decrease year-over-year.
- Lixte Biotechnology Holdings Inc. operating income for the twelve months ending September 30, 2013 was -1.9 M, a 0.82% increase year-over-year.
- Lixte Biotechnology Holdings Inc. annual operating income for 2015 was -2.6 M, a 92.49% increase from 2013.
- Lixte Biotechnology Holdings Inc. annual operating income for 2013 was -1.4 M, a 34.71% decrease from 2012.
- Lixte Biotechnology Holdings Inc. annual operating income for 2012 was -2.1 M, a 12.71% increase from 2011.
- Lixte Biotechnology Holdings Inc. annual operating income for 2011 was -1.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lixte Biotechnology Holdings Inc. Operating Income — FAQ
Lixte Biotechnology Holdings Inc. (LIXT) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Lixte Biotechnology Holdings Inc.'s operating income?
Lixte Biotechnology Holdings Inc. (LIXT) reported operating income of -$3M for fiscal 2015.
Where can I see LIXT's operating income history?
The chart and table above show Lixte Biotechnology Holdings Inc.'s operating income by year and by quarter, including the growth rate.